There was good news and bad news for Lundbeck in its quest to protect its antidepressant Lexapro from generic competition, after the firm won a legal challenge in Denmark but lost its case in Spain.

The City Court in Elsinore has granted the drugmaker a preliminary injunction meaning that generic versions of Cipralex (escitalopram) have to be removed from the market in Denmark, although this decision can be appealed, it stressed.

On the flip side, however, a court in Spain has decided to lift an injunction made against companies preparing to market a copycat version of Lundbeck’s drug in the country.

Consequently, the firm, which will appeal this ruling, said it is expecting generic forms of escitalopram to be available in Spain “within a short period of time”, and that this will have a “moderate” impact on Cipralex sales on the Spanish market in 2010.